Cargando…

Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity

Detalles Bibliográficos
Autores principales:	Batlle, Daniel, Monteil, Vanessa, Garreta, Elena, Hassler, Luise, Wysocki, Jan, Chandar, Vasuretha, Schwartz, Robert E., Mirazimi, Ali, Montserrat, Nuria, Bader, Michael, Penninger, Josef M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134488/ https://www.ncbi.nlm.nih.gov/pubmed/35623327 http://dx.doi.org/10.1016/j.cell.2022.05.004

Ejemplares similares

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
por: Monteil, Vanessa, et al.
Publicado: (2020)

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
por: Monteil, Vanessa, et al.
Publicado: (2020)

Human recombinant soluble ACE2 in severe COVID-19
por: Zoufaly, Alexander, et al.
Publicado: (2020)

On the essentiality of the angiotensin converting enzyme 2 receptor for SARS‐CoV‐2 infection and the potential of soluble angiotensin converting enzyme 2 proteins as universal approach for variants causing COVID‐19
por: Hassler, Luise, et al.
Publicado: (2022)

Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infection
por: Hassler, Luise, et al.
Publicado: (2023)

Response to Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
por: Yeung, Man Lung, et al.
Publicado: (2022)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor
por: Capraz, Tümay, et al.
Publicado: (2021)

Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants
por: Wirnsberger, Gerald, et al.
Publicado: (2021)

ACE2 – From the renin–angiotensin system to gut microbiota and malnutrition
por: Perlot, Thomas, et al.
Publicado: (2013)

Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
por: Kuba, Keiji, et al.
Publicado: (2021)

Reduced plasma ACE2 activity in dialysis patients: another piece in the conundrum of factors involved in hypertension and cardiovascular morbidity?
por: Wysocki, Jan, et al.
Publicado: (2013)

Pharmacologic modulation of ACE2 expression
por: Soler, María José, et al.
Publicado: (2008)

A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
por: Garreta, Elena, et al.
Publicado: (2022)

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level
por: Zhu, Rong, et al.
Publicado: (2022)

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
por: Abd El-Aziz, Tarek Mohamed, et al.
Publicado: (2020)

ACE2 – das missbrauchte Multitalent
por: Bader, M.
Publicado: (2020)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2
por: C., Selvaa Kumar, et al.
Publicado: (2020)

Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants
por: Monteil, Vanessa, et al.
Publicado: (2022)

CD36/Sirtuin 1 Axis Impairment Contributes to Hepatic Steatosis in ACE2-Deficient Mice
por: Nunes-Souza, Valéria, et al.
Publicado: (2016)

Author Correction: Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level
por: Zhu, Rong, et al.
Publicado: (2023)

Lessons from SARS: control of acute lung failure by the SARS receptor ACE2
por: Kuba, Keiji, et al.
Publicado: (2006)

ACE2 deficiency increases NADPH‐mediated oxidative stress in the kidney
por: Wysocki, Jan, et al.
Publicado: (2014)

Role of ACE, ACE2 and Neprilysin in the Kidney
por: Chappell, Mark C.
Publicado: (2007)

Soluble ACE2 and TMPRSS2 Levels in the Serum of Asthmatic Patients
por: Lee, Ji-Hyang, et al.
Publicado: (2022)

Engineered soluble ACE2 receptor: Responding to change with change
por: Li, Guangyao, et al.
Publicado: (2023)

Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
por: Clarke, Nicola E., et al.
Publicado: (2012)

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
por: Zhang, Haibo, et al.
Publicado: (2020)

Emerging importance of ACE2 in external stratified epithelial tissues
por: Kaplan, Nihal, et al.
Publicado: (2021)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
por: Osman, Ikram Omar, et al.
Publicado: (2021)

Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
por: Oudit, Gavin Y., et al.
Publicado: (2010)

Blockade of SARS-CoV-2 infection by recombinant soluble ACE2
por: Alhenc-Gelas, Francois, et al.
Publicado: (2020)

ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology
por: Gawish, Riem, et al.
Publicado: (2022)

Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients
por: Akbari, Mohammadarian, et al.
Publicado: (2022)

ACE inhibitors on ACE1, ACE2, and TMPRSS2 expression and spheroid attachment on human endometrial Ishikawa cells
por: Fernando, Sudini R., et al.
Publicado: (2022)

Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells
por: Garreta, Elena, et al.
Publicado: (2022)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
por: Tyrankiewicz, Urszula, et al.
Publicado: (2021)

Effect of Insulin on ACE2 Activity and Kidney Function in the Non-Obese Diabetic Mouse
por: Riera, Marta, et al.
Publicado: (2014)

ACE2 Receptor and Its Isoform Short-ACE2 Are Expressed on Human Spermatozoa
por: Ramal-Sanchez, Marina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_urb3bcfo3cms8201u82nji809p